Electron transport
chain and oxidative
phosphorylation
`
ism
NADH electrons from glycolysis enter mitochondria via the malate-aspartate or glycerol-3phosphate shuttle. FADH2 electrons are transferred to complex II (at a lower energy level than
NADH). The passage of electrons results in the formation of a proton gradient that, coupled to
oxidative phosphorylation, drives the production of ATP.
ADP + Pi
FADH2
NADH NAD
FAD
Complex I
2,3-Dinitrophenol
Aspirin overdose
H+
Complex II
(succinate
dehydrogenase)
Rotenone
ATP
/2O2 + 2H H2O
+
Mitochondrial
matrix
Inner mitochondrial
membrane
Cytochrome c
CoQ
P PROD
aT
ED
VI
uC
II
Complex III
Antimycin A
H+
Complex IV
Cyanide,
CO
H+
Complex V
Oligomycin
Intermembrane
space
H+
a aTP SYNTHaSE
laTION POISONS
Electron transport
inhibitors
ATP synthase
inhibitors
Oligomycin.
Uncoupling agents
Gluconeogenesis,
irreversible enzymes
Pyruvate carboxylase
Phosphoenolpyruvate
carboxykinase
In cytosol. Oxaloacetate
phosphoenolpyruvate.
Requires GTP.
Fructose-1,6bisphosphatase
In cytosol. Fructose-1,6-bisphosphate
fructose-6-phosphate.
Glucose-6phosphatase
89
90
II
Biochemistry
Provides a source of NADPH from abundantly available glucose-6-P (NADPH is required for
reductive reactions, eg, glutathione reduction inside RBCs, fatty acid and cholesterol biosynthesis).
Additionally, this pathway yields ribose for nucleotide synthesis and glycolytic intermediates. 2
distinct phases (oxidative and nonoxidative), both of which occur in the cytoplasm. No ATP is
used or produced.
Sites: lactating mammary glands, liver, adrenal cortex (sites of fatty acid or steroid synthesis), RBCs.
TIONS
REaC
Oxidative
(irreversible)
Nonoxidative
(reversible)
Glucose-6-phosphate
dehydrogenase
deficiency
`
ism
NADP+
Glucose-6-Pi
Ribulose-5-Pi
PRODuCTS
NADPH
Glucose-6-P dehydrogenase
Rate-limiting step
Phosphopentose isomerase,
transketolases
Requires B1
Ribose-5-Pi
Glyceraldehyde-3-phosphate
Fructose-6-P
NADP+
Glucose-6-P
Glucose-6-P
dehydrogenase
6-phosphogluconate
CO2
2 NADPH
Ribulose-5-Pi
Glutathione
reductase
NADPH
H2O2
Glutathione
peroxidase
GSSG
(oxidized)
2H2O
Biochemistry
`
ism
91
II
Fructose intolerance
Fructose
ATP
Fructose-1-P
Aldolase B
Glyceraldehyde
ADP
e
Trios
ATP
NADH
se
kina
Glyceraldehyde-3-P
Glycolysis
ADP
NAD+
Glycerol
Classic galactosemia
Galactose
Galactokinase
ATP
Aldose
reductase
ADP
Galactose-1-P
Uridyltransferase
UDP-Glu UDP-Gal
4-epimerase
Galactitol
Glucose-1-P
Glycolysis/glycogenesis
92
II
Sorbitol
Biochemistry
`
ism
An alternative method of trapping glucose in the cell is to convert it to its alcohol counterpart,
called sorbitol, via aldose reductase. Some tissues then convert sorbitol to fructose using
sorbitol dehydrogenase; tissues with an insufficient amount/activity of this enzyme are at risk
for intracellular sorbitol accumulation, causing osmotic damage (eg, cataracts, retinopathy, and
peripheral neuropathy seen with chronic hyperglycemia in diabetes).
High blood levels of galactose also result in conversion to the osmotically active galactitol via aldose
reductase.
Liver, ovaries, and seminal vesicles have both enzymes.
Glucose
Aldose reductase
Sorbitol
NADPH
Sorbitol dehydrogenase
Fructose
NAD+
Schwann cells, retina, and kidneys have only aldose reductase. Lens has primarily aldose reductase.
Glucose
Aldose reductase
Sorbitol
NADPH
Lactase deficiency
Insufficient lactase enzyme dietary lactose intolerance. Lactase functions on the brush border to
digest lactose (in human and cow milk) into glucose and galactose.
Primary: age-dependent decline after childhood (absence of lactase-persistent allele), common in
people of Asian, African, or Native American descent.
Secondary: loss of brush border due to gastroenteritis (eg, rotavirus), autoimmune disease, etc.
Congenital lactase deficiency: rare, due to defective gene.
Stool demonstrates pH and breath shows hydrogen content with lactose hydrogen breath test.
Intestinal biopsy reveals normal mucosa in patients with hereditary lactose intolerance.
FINDINGS
MENT
TREaT
Amino acids
Essential
Acidic
Basic
Biochemistry
Urea cycle
93
II
`
ism
NH2
tran Ornit
sca hin
rba e
my
Ornithine
AMP + PPi
Argininosuccinate
Cytoplasm
(liver)
Urea
To kidney
A rg
Aspartate
ATP
nase
e
las
u cci
CO2
Mitochondria
Arg
H2O
rg
se
ini
ina
nos
NH2
Aspartate
Citrulline
2 ADP + Pi
Carbamoyl
phosphate
Urea
NH3
2 ATP
te
cina
suc se
no eta
ini ynth
s
N-acetylglutamate
(allosteric activator)
Carbamoyl
phosphate
synthetase I
CO2 + NH3
Arginine
Fumarate
Muscle
Amino acids
(NH3)
-Ketoglutarate
Liver
Alanine
(NH3)
y
Cahill cycle
lucose
Glucose
-Ketoacids
Glutamate (NH3)
Pyruvate
Asterixis
-Ketoglutarate
Glucos
Glucose
Cori cycle
Lactate
Hyperammonemia
Alanine
(NH3)
Pyruvate
Glutamate (NH3)
Lactate
Urea (NH3)
FIN
ISH
94
II
Biochemistry
`
ism
N-acetylglutamate
synthase deficiency
Ornithine
transcarbamylase
deficiency
Most common urea cycle disorder. X-linked recessive (vs other urea cycle enzyme deficiencies,
which are autosomal recessive). Interferes with the bodys ability to eliminate ammonia. Often
evident in the first few days of life, but may present later. Excess carbamoyl phosphate is converted
to orotic acid (part of the pyrimidine synthesis pathway).
Findings: orotic acid in blood and urine, BUN, symptoms of hyperammonemia. No
megaloblastic anemia (vs orotic aciduria).
Phenylalanine
BH4
BH4
Niacin
B2, B6
Tryptophan
Tyrosine
Melanin
Glycine
B6
NAD+/NADP+
BH4, B6
Serotonin
Histidine
Dopa
B6
B6
B6
Histamine
Porphyrin
GABA
Glutamate
Glutathione
Creatine
Urea
Arginine
BH4
Melatonin
Nitric oxide
Heme
SAM
Vitamin C
Dopamine
NE
Epi